Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1. Tanase MG, Djilani L, Lamontagne R, Derbel R, et al. Neurol Genet 2026;12:e200361.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tanase MG, Djilani L, Lamontagne R, Derbel R, et al. Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1. Neurol Genet 2026;12:e200361.
PMID: 41878223